Literature DB >> 2266684

Anaphylactoid reactions during hemodialysis on AN69 membranes in patients receiving ACE inhibitors.

C Tielemans1, P Madhoun, M Lenaers, L Schandene, M Goldman, J L Vanherweghem.   

Abstract

We report five life-threatening anaphylactoid reactions occurring within the very first minutes of hemodialysis on polyacrylonitrile (AN69) capillary dialyzers in three patients receiving ACE inhibitors. Such reactions were not observed either in patients treated with ACE inhibitors but dialyzed on other membranes (N = 9), nor in patients on AN69 who did not receive ACE inhibitors (N = 19). These anaphylactoid reactions could be due to bradykinin accumulation, as a result of both increased synthesis--by interaction of blood with the AN69 polymer--and catabolism blockade by ACE inhibitors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2266684     DOI: 10.1038/ki.1990.301

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  19 in total

Review 1.  Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal disease.

Authors:  D A Sica; T W Gehr; A Fernandez
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

2.  A case of anaphylactoid reaction to acetate in acetate-containing bicarbonate dialysate.

Authors:  Taro Misaki; Yumiko Suzuki; Yoshitaka Naito; Tempei Shiooka; Taisuke Isozaki
Journal:  CEN Case Rep       Date:  2014-09-04

Review 3.  Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus.

Authors:  K L Goa; M Haria; M I Wilde
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 4.  ACE inhibitors. Drug interactions of clinical significance.

Authors:  C Mignat; T Unger
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

Review 5.  ACE inhibitors in non-diabetic renal disease.

Authors:  R J Fluck; A E Raine
Journal:  Br Heart J       Date:  1994-09

6.  Bradykinin forming capacity of oversulfated chondroitin sulfate contaminated heparin in vitro.

Authors:  Albert Adam; Nicolas Montpas; David Keire; Anik Désormeaux; Nancy J Brown; François Marceau; Benjamin Westenberger
Journal:  Biomaterials       Date:  2010-04-27       Impact factor: 12.479

Review 7.  Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients.

Authors:  H D Langtry; A Markham
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 3.923

Review 8.  Diagnosis, Treatment, and Prevention of Hemodialysis Emergencies.

Authors:  Manish Saha; Michael Allon
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-09       Impact factor: 8.237

Review 9.  Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure.

Authors:  J Hoyer; K L Schulte; T Lenz
Journal:  Clin Pharmacokinet       Date:  1993-03       Impact factor: 6.447

Review 10.  Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertension.

Authors:  P A Todd; K L Goa
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.